Average Co-Inventor Count = 8.55
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (27 from 2,405 patents)
2. Merck + Co., Inc. (7 from 4,770 patents)
3. Other (1 from 833,002 patents)
4. Merck Sharp & Dohme LLC (1 from 13 patents)
5. Merck Shapr & Dohme Corp. (1 from 1 patent)
37 patents:
1. 12528786 - Plasma kallikrein inhibitors
2. 12459927 - Plasma kallikrein inhibitors
3. 12440496 - Natriuretic peptide receptor a agonists useful for the treatment of cardiometabolic diseases, kidney disease and diabetes
4. 11014920 - Factor XIIa inhibitors
5. 10875851 - Factor XIIa inhibitors
6. 10800827 - Insulin receptor partial agonists
7. 10689430 - Insulin receptor partial agonists
8. 10508108 - Tricyclic compounds as inhibitors of mutant IDH enzymes
9. 10442819 - Tricyclic compounds as inhibitors of mutant IDH enzymes
10. 10183981 - Insulin receptor partial agonists
11. 10017556 - Insulin receptor partial agonists
12. 9868733 - Azabenzimidazole tetrahydrofuran derivatives
13. 9751881 - Inhibitors of the renal outer medullary potassium channel
14. 9556193 - Benzimidazole hexahydrofuro[3,2-b]furan derivatives
15. 9540364 - Benzimidazole tetrahydrofuran derivatives